Close
4

Bora CDMO Bora CDMO

X

CAS 760937-92-6 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 760937-92-6
Also known as: 760937-92-6, Teneligliptin [inn], Teliglietin, [(2s,4s)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone, Mp-513, Teneligliptin hydrobromide
Molecular Formula
C22H30N6OS
Molecular Weight
426.6  g/mol
InChI Key
WGRQANOPCQRCME-PMACEKPBSA-N
FDA UNII
28ZHI4CF9C

Teneligliptin is a long-acting, orally bioavailable, pyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Teneligliptin may also reduce plasma triglyceride levels through a sustained increase in GLP-1 levels.
1 2D Structure

CAS 760937-92-6

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone
2.1.2 InChI
InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1
2.1.3 InChI Key
WGRQANOPCQRCME-PMACEKPBSA-N
2.1.4 Canonical SMILES
CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5
2.1.5 Isomeric SMILES
CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5
2.2 Other Identifiers
2.2.1 UNII
28ZHI4CF9C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine

2.3.2 Depositor-Supplied Synonyms

1. 760937-92-6

2. Teneligliptin [inn]

3. Teliglietin

4. [(2s,4s)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone

5. Mp-513

6. Teneligliptin Hydrobromide

7. 28zhi4cf9c

8. Chembl2147777

9. Teneligliptin (inn)

10. 906093-29-6

11. {(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone

12. Unii-28zhi4cf9c

13. Teneli

14. ((2s,4s)-4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(1,3-thiazolidin-3-yl)methanone

15. Cs-0882

16. Teneligliptin [mi]

17. Schembl161778

18. Teneligliptin [who-dd]

19. Gtpl9906

20. Dtxsid30997419

21. Chebi:136042

22. Mp513

23. Amy40806

24. Bdbm50391565

25. Mfcd13195565

26. Zinc36520254

27. Akos025401965

28. Db11950

29. Compound 8g [pmid: 22959556]

30. Ncgc00378896-02

31. Ncgc00378896-03

32. Ncgc00378896-04

33. ((2s,4s)-4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone

34. Ac-27649

35. As-83281

36. Hy-14806

37. D08616

38. 937t926

39. Teneligliptin (contain Around 5% Hexanes)

40. Q15269678

41. ((2s,4s)-4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone Hydrobromide

42. {4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone

43. 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine

44. M51

2.4 Create Date
2006-11-20
3 Chemical and Physical Properties
Molecular Weight 426.6 g/mol
Molecular Formula C22H30N6OS
XLogP32.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass426.22018078 g/mol
Monoisotopic Mass426.22018078 g/mol
Topological Polar Surface Area81.9 Ų
Heavy Atom Count30
Formal Charge0
Complexity594
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 ATC Code

A - Alimentary tract and metabolism

A10 - Drugs used in diabetes

A10B - Blood glucose lowering drugs, excl. insulins

A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors

A10BH08 - Teneligliptin


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY